Hospitalized COVID-19 patients experience a high rate of thromboembolic complications, according to new findings published in Thrombosis Research.

The high mortality rates from COVID-19 among black patients and other racial/ethnic minorities put a much-needed spotlight on the “deep-rooted failures” of the U.S. healthcare system to improve care for cardiovascular disease (CVD), according to a new commentary.

Cardiologs has announced the beginning of a new clinical trial that will involve monitoring the cardiac health of COVID-19 patients being treated with hydroxychloroquine and azithromycin.

Taking evolocumab to lower LDL cholesterol can lead to significant reductions in a patient’s risk of myocardial infarction (MI), according to new findings published by JAMA Cardiology.

The American Medical Association (AMA) has published new guidelines to help physicians provide care during the ongoing COVID-19 pandemic.

The first known death from COVID-19 in the United States was caused by a ventricular rupture.  

Researchers have launched a new multi-center clinical trial aimed at learning more about how various blood pressure medications impact the health of patients with COVID-19.   

Women are prescribed fewer drugs after a heart attack than men—and they are more likely to die afterward as a result of that disparity.

Work-related stress is associated with an increased risk of peripheral artery disease (PAD), according to a new study published in the Journal of the American Heart Association.